Joel Greenblatt's EW Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 122,453 shares of Edwards Lifesciences Corporation (EW) worth $10.44 M, representing 0.04% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 38 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in EW, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2014, adding 1.12 M shares. Largest reduction occurred in Q2 2015, reducing 783,318 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +88,997 | Add 266.01% | 122,453 | $85.25 |
| Q3 2025 | -9,839 | Reduce 22.73% | 33,456 | $77.77 |
| Q2 2025 | -365 | Reduce 0.84% | 43,295 | $78.21 |
| Q1 2025 | +27,237 | Add 165.85% | 43,660 | $72.48 |
| Q4 2024 | +8,444 | Add 105.83% | 16,423 | $74.03 |
| Q3 2024 | -3,879 | Reduce 32.71% | 7,979 | $65.99 |
| Q2 2024 | +30 | Add 0.25% | 11,858 | $92.37 |
| Q1 2024 | -6,468 | Reduce 35.35% | 11,828 | $95.56 |
| Q4 2023 | +6,738 | Add 58.30% | 18,296 | $76.25 |
| Q3 2023 | -10,835 | Reduce 48.39% | 11,558 | $69.28 |
| Q2 2023 | -24,129 | Reduce 51.87% | 22,393 | $94.33 |
| Q1 2023 | -4,731 | Reduce 9.23% | 46,522 | $82.73 |
| Q4 2022 | +24,513 | Add 91.67% | 51,253 | $74.61 |
| Q3 2022 | +20,684 | Add 341.55% | 26,740 | $82.65 |
| Q2 2022 | -12,995 | Reduce 68.21% | 6,056 | $95.11 |
| Q1 2022 | +13,398 | Add 237.01% | 19,051 | $117.74 |
| Q4 2021 | -4,593 | Reduce 44.83% | 5,653 | $129.49 |
| Q3 2021 | +10,246 | New Buy | 10,246 | $113.21 |
| Q3 2020 | -16,482 | Sold Out | 0 | $0.00 |
| Q2 2020 | +16,482 | New Buy | 16,482 | $69.11 |
| Q1 2020 | -89,811 | Sold Out | 0 | $0.00 |
| Q4 2019 | +89,811 | New Buy | 89,811 | $77.76 |
| Q1 2018 | -112,623 | Sold Out | 0 | $0.00 |
| Q4 2017 | +88,815 | Add 373.05% | 112,623 | $37.57 |
| Q3 2017 | +23,808 | New Buy | 23,808 | $36.42 |
| Q3 2016 | -17,511 | Sold Out | 0 | $0.00 |
| Q2 2016 | +17,511 | New Buy | 17,511 | $33.24 |
| Q4 2015 | -46,662 | Sold Out | 0 | $0.00 |
| Q3 2015 | -618,822 | Reduce 92.99% | 46,662 | $23.70 |
| Q2 2015 | -783,318 | Reduce 54.07% | 665,484 | $23.74 |
| Q1 2015 | -38,454 | Reduce 2.59% | 1.45 M | $23.74 |
| Q4 2014 | -150,708 | Reduce 9.20% | 1.49 M | $21.23 |
| Q3 2014 | +83,526 | Add 5.37% | 1.64 M | $17.02 |
| Q2 2014 | +1.12 M | Add 261.38% | 1.55 M | $14.31 |
| Q1 2014 | -276,426 | Reduce 39.12% | 430,134 | $12.36 |
| Q4 2013 | +520,014 | Add 278.76% | 706,560 | $10.96 |
| Q3 2013 | -66,186 | Reduce 26.19% | 186,546 | $11.61 |
| Q2 2013 | +252,732 | Add 0.00% | 252,732 | $11.20 |
Joel Greenblatt's Edwards Lifesciences Corporation Investment FAQs
Joel Greenblatt first purchased Edwards Lifesciences Corporation (EW) in Q2 2013, acquiring 252,732 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Edwards Lifesciences Corporation (EW) for 38 quarters since Q2 2013.
Joel Greenblatt's largest addition to Edwards Lifesciences Corporation (EW) was in Q2 2014, adding 1,554,438 shares worth $22.24 M.
According to the latest 13F filing for Q4 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 122,453 shares of Edwards Lifesciences Corporation (EW), valued at approximately $10.44 M.
As of the Q4 2025 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.04% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Edwards Lifesciences Corporation (EW) was 1,637,964 shares, as reported at the end of Q3 2014.